149 related articles for article (PubMed ID: 3689423)
1. Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.
el Kouni MH; Messier NJ; Cha S
Biochem Pharmacol; 1987 Nov; 36(22):3815-21. PubMed ID: 3689423
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of adenosine analogues by Schistosoma mansoni and the effect of nucleoside transport inhibitors.
el Kouni MH; Cha S
Biochem Pharmacol; 1987 Apr; 36(7):1099-106. PubMed ID: 3566804
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate.
el Kouni MH; Diop D; Cha S
Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6667-70. PubMed ID: 6579551
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5'-monophosphate.
el Kouni MH; Knopf PM; Cha SM
Biochem Pharmacol; 1985 Nov; 34(21):3921-3. PubMed ID: 3933515
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis.
el Kouni MH
Biochem Pharmacol; 1991 Mar; 41(5):815-20. PubMed ID: 1900158
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice against lethal dosages of nebularine by nitrobenzylthioinosine, an inhibitor of nucleoside transport.
Paterson AR; Paran JH; Yang S; Lynch TP
Cancer Res; 1979 Sep; 39(9):3607-11. PubMed ID: 476687
[TBL] [Abstract][Full Text] [Related]
7. Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.
el Kouni MH; Diop D; O'Shea P; Carlisle R; Sommadossi JP
Antimicrob Agents Chemother; 1989 Jun; 33(6):824-7. PubMed ID: 2764531
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mouse neoplasms with high doses of tubercidin.
Lynch TP; Jakobs ES; Paran JH; Paterson AR
Cancer Res; 1981 Aug; 41(8):3200-4. PubMed ID: 7248975
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
[TBL] [Abstract][Full Text] [Related]
11. Therapy of mouse leukemia L1210 with combinations of nebularine and nitrobenzylthioinosine 5'-monophosphate.
Lynch TP; Paran JH; Paterson AR
Cancer Res; 1981 Feb; 41(2):560-5. PubMed ID: 7448803
[TBL] [Abstract][Full Text] [Related]
12. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
Prus KL; Averett DR; Zimmerman TP
Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of toxicity and tissue distribution of tubercidin in mice by nitrobenzylthioinosine 5'-monophosphate.
Kolassa N; Jakobs ES; Buzzell GR; Paterson AR
Biochem Pharmacol; 1982 May; 31(10):1863-74. PubMed ID: 7104018
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the tubercidin antileishmania action associated with an inhibitor of the nucleoside transport.
Aoki JI; Yamashiro-Kanashiro EH; Ramos DC; Cotrim PC
Parasitol Res; 2009 Jan; 104(2):223-8. PubMed ID: 18787843
[TBL] [Abstract][Full Text] [Related]
15. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
16. In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters.
Baer HP; Serignese V; Moorji A; Van Belle H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):365-9. PubMed ID: 1852220
[TBL] [Abstract][Full Text] [Related]
17. Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.
Al Safarjalani ON; Naguib FN; El Kouni MH
Antimicrob Agents Chemother; 2003 Oct; 47(10):3247-51. PubMed ID: 14506037
[TBL] [Abstract][Full Text] [Related]
18. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
19. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
20. Induction of nucleoside transport sites into the host cell membrane of Babesia bovis infected erythrocytes.
Gero AM
Mol Biochem Parasitol; 1989 Jul; 35(3):269-76. PubMed ID: 2747745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
